109403 ⎘
Active agents used in cell culture processes, e.g. differentation; Enzymes; Transferases (EC 2.) Glycosyltransferases (EC 2.4.)
COMPOSITIONS AND METHODS FOR PRODUCTION OF EXOFUCOSYLATED CELLS FOR CLINICAL APPLICATIONS
#2METHODS AND PRODUCTS FOR IMPROVING SPERM QUALITY
#3COMPOSITIONS AND SYSTEMS FOR COMBINATORIAL THERAPIES CONTAINING FUCOSYLATED CELLS AND IMMUNE CHECKPOINT INHIBITORS AND METHODS OF PRODUCTION AND USE THEREOF
#4SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#5Methods of Epigenetic Analysis
#6SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#7AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA, 1,3 FUCOSYLTRANSFERASE
#8In Vitro Breeding Systems and Methods in Livestock
#9COMPOSITIONS COMPRISING HISTONE ACETYLTRANSFERASE INHIBITORS OR REVERSE TRANSCRIPTASE INHIBITORS AND USE THEREOF
#10METHODS AND PRODUCTS FOR IMPROVING SPERM QUALITY
#11SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#12CLINICAL-GRADE THERAPEUTIC PROGENITORS GENERATED FROM TANKYRASE/PARP-INHIBITED PLURIPOTENT STEM CELL BANKS
#13SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#14AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1,3 FUCOSYLTRANSFERASE
#15Selective oxidation of 5-methylcytosine by TET-family proteins
#16SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#17SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#18METHOD FOR PRODUCING PLURIPOTENT STEM CELL POPULATION
#19Augmentation of Cell Therapy Efficacy Including Treatment with Alpha 1,3 Fucosyltransferase
#20PRODUCTION OF MEGAKARYOCYTES AND PLATELETS IN A CO-CULTURE SYSTEM
#21COMPOSITIONS AND METHODS FOR GENERATING HUMAN YOLK SAC-LIKE HEMATOPOIETIC CELLS
#22Methods to improve cell therapy
#23MANUFACTURE AND CRYOPRESERVATION OF FUCOSYLATED CELLS FOR THERAPEUTIC USE
#24Selective oxidation of 5-methylcytosine by TET-family proteins
#25REPROGRAMMING METHODS AND CELL CULTURE PLATFORMS
#26Method for long-term ex vivo maintenance or expansion of human erythroblast, human megakaryocyte-erythroid progenitor, or human common myeloid progenitor cell and application thereof
#27Methods of Epigenetic Analysis
#28IN VITRO METHOD OF DIFFERENTIATING A HUMAN PLURIPOTENT STEM CELL POPULATION INTO A CARDIOMYOCYTE CELL POPULATION
#29CHEMICAL COCKTAIL FOR INDUCING SENESCENCE IN HUMAN NEURONS TO PROMOTE DISEASE MODELING AND DRUG DISCOVERY
#30NAÏVE HUMAN EMBRYONIC VASCULAR PROGENITOR CELLS AND METHODS OF TREATMENT
#31Methods of epigenetic analysis
#32METHODS AND PRODUCTS FOR IMPROVING SPERM QUALITY
#33COMPOSITIONS AND METHODS FOR PRODUCTION OF EXOFUCOSYLATED CELLS FOR CLINICAL APPLICATIONS
#34N-Glycosylation
#35N-Glycosylation
#36N-Glycosylation
#37Methods for selective inhibition of pluripotent stem cells
#38COMPOSITIONS AND METHODS FOR PREPARING CD34NEG STEM CELLS FOR TRANSPLANT
#39Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells
#40Methods for selective inhibition of pluripotent stem cells
#41METHOD FOR PREPARING CORNEAL TISSUE
#42Production of N-glycoproteins for enzyme assisted glycomodification
#43Manufacture and Cryopreservation of Fucosylated Cells for Therapeutic Use
#44Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase
#45Resetting pluripotent stem cells
#46Method of inducing beta cells from urine-derived cells using small molecules
#47N-glycosylation
#48Differentiation of hepatocyte-like cells from stem cells
#49Methods and Compositions For Treating Disease
#50Manufacture and Cryopreservation of Fucosylated Cells for Therapeutic Use
#51Reprogramming methods and cell culture platforms
#52Viral resistant cells and uses thereof
#53Methods for selective inhibition of pluripotent stem cells
#54Culturing pluripotent stem cells
#55Compositions and methods of using transposons
#56ENZYMATICAL MODIFICATION OF CELL GLYCOSYLATION USING SERUM ALBUMIN AND DIVALENT CATIONS
#57Hematopoietic progenitor cell populations having affinity for E-selectin / L-selectin
#58Methods to improve cell therapy
#59Method for increasing the E-selectin binding affinity of a population of cells expressing a CD44 polypeptide
#60Selective oxidation of 5-methylcytosine by TET-family proteins
#61Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide
#62Enzymatical modification of cell glycosylation using serum albumin and divalent cations
#63AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1-3 FUCOSYLTRANSFERASE
#64Methods and Compositions for Treating Disease